Healthy men help scientists track how a lymphoma drug leaves the body
NCT ID NCT07454863
First seen Mar 10, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This study looked at how healthy men absorb, break down, and eliminate a drug called DZD8586, which is being developed for non-Hodgkin lymphoma. Six healthy male volunteers took a single dose with a tiny radioactive marker so scientists could track it in blood, urine, and stool. The goal was to understand how the drug moves through the body, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, NON-HODGKIN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214062, China
Conditions
Explore the condition pages connected to this study.